Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.
Fazekas F, Deisenhammer F, Strasser-Fuchs S, Nahler G, Mamoli B. Fazekas F, et al. Among authors: mamoli b. Lancet. 1997 Mar 1;349(9052):589-93. doi: 10.1016/s0140-6736(96)09377-4. Lancet. 1997. PMID: 9057729 Clinical Trial.
Epilepsia partialis continua in multiple sclerosis.
Spatt J, Goldenberg G, Mamoli B. Spatt J, et al. Among authors: mamoli b. Lancet. 1995 Mar 11;345(8950):658-9. doi: 10.1016/s0140-6736(95)90566-9. Lancet. 1995. PMID: 7898217 No abstract available.
Prevalence of multiple sclerosis in Austria. Results of a nationwide survey.
Baumhackl U, Eibl G, Ganzinger U, Hartung HP, Mamoli B, Pfeiffer KP, Fazekas F, Vass K; Austrian MS Study Committee. Baumhackl U, et al. Among authors: mamoli b. Neuroepidemiology. 2002 Sep-Oct;21(5):226-34. doi: 10.1159/000065640. Neuroepidemiology. 2002. PMID: 12207150
The Austrian Immunoglobulin in MS (AIMS) study: final analysis.
Strasser-Fuchs S, Fazekas F, Deisenhammer F, Nahler G, Mamoli B. Strasser-Fuchs S, et al. Among authors: mamoli b. Mult Scler. 2000 Oct;6 Suppl 2:S9-13. Mult Scler. 2000. PMID: 11188778 Clinical Trial.
Treatment effects of monthly intravenous immunoglobulin on patients with relapsing-remitting multiple sclerosis: further analyses of the Austrian Immunoglobulin in MS study.
Fazekas F, Deisenhammer F, Strasser-Fuchs S, Nahler G, Mamoli B. Fazekas F, et al. Among authors: mamoli b. Mult Scler. 1997 Apr;3(2):137-41. doi: 10.1177/135245859700300214. Mult Scler. 1997. PMID: 9291168 Clinical Trial.
Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST).
Aichner FT, Fazekas F, Brainin M, Pölz W, Mamoli B, Zeiler K. Aichner FT, et al. Among authors: mamoli b. Stroke. 1998 Apr;29(4):743-9. doi: 10.1161/01.str.29.4.743. Stroke. 1998. PMID: 9550505 Clinical Trial.
Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis.
Finsterer J, Grass R, Stöllberger C, Mamoli B. Finsterer J, et al. Among authors: mamoli b. Clin Neuropharmacol. 1998 Jul-Aug;21(4):258-61. Clin Neuropharmacol. 1998. PMID: 9704169
Simple dysphasic seizures as the sole manifestation of relapse in multiple sclerosis.
Spatt J, Goldenberg G, Mamoli B. Spatt J, et al. Among authors: mamoli b. Epilepsia. 1994 Nov-Dec;35(6):1342-5. doi: 10.1111/j.1528-1157.1994.tb01809.x. Epilepsia. 1994. PMID: 7988531
Predictors for negative attitudes toward subjects with epilepsy: a representative survey in the general public in Austria.
Spatt J, Bauer G, Baumgartner C, Feucht M, Graf M, Mamoli B, Trinka E; Austrian Section of the International League Against Epilepsy. Spatt J, et al. Among authors: mamoli b. Epilepsia. 2005 May;46(5):736-42. doi: 10.1111/j.1528-1167.2005.52404.x. Epilepsia. 2005. PMID: 15857441 Free article.
Epileptic and non-epileptic seizures in multiple sclerosis.
Spatt J, Chaix R, Mamoli B. Spatt J, et al. Among authors: mamoli b. J Neurol. 2001 Jan;248(1):2-9. doi: 10.1007/s004150170262. J Neurol. 2001. PMID: 11266015 Review.
146 results
Jump to page
Feedback